Immunogenicity and safety of an intradermal fractional third dose of ChAdOx1 nCoV-19/AZD1222 vaccine compared with those of a standard intramuscular third dose in volunteers who previously received two doses of CoronaVac: A randomized controlled trial

Kriangkrai Tawinprai; Taweegrit Siripongboonsitti; Thachanun Porntharukchareon; Kasiruck Wittayasak; Nawarat Thonwirak; Kamonwan Soonklang; Gaidganok Sornsamdang; Chirayu Auewarakul; Nithi Mahanonda

Vaccine (2022) - Comments
pubmed: 35210118 doi: 10.1016/j.vaccine.2022.02.019 issn: 0264-410x issn: 1873-2518

Kriangkrai Tawinprai, Taweegrit Siripongboonsitti, Thachanun Porntharukchareon, Kasiruck Wittayasak, Nawarat Thonwirak, Kamonwan Soonklang, Gaidganok Sornsamdang, Chirayu Auewarakul, Nithi Mahanonda